Virtus ETF Advisers LLC Adverum Biotechnologies, Inc. Transaction History

Virtus ETF Advisers LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $100,516 - $138,643	-57,768 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $6,275 - $10,861	-3,017 Reduced 4.96%	57,768 $125,000
Q2 2021 Aug 10, 2021	BUY	$3.36 - $10.56 $132,189 - $415,451	39,342 Added 183.47%	60,785 $213,000
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $3,574 - $5,542	386 Added 1.83%	21,443 $211,000
Q4 2020 Feb 12, 2021	BUY	$9.84 - $14.26 $64,944 - $94,116	6,600 Added 45.65%	21,057 $228,000
Q3 2020 Nov 13, 2020	SELL	$10.3 - $21.64 $20,363 - $42,782	-1,977 Reduced 12.03%	14,457 $149,000
Q2 2020 Aug 05, 2020	SELL	$8.53 - $25.64 $150,801 - $453,289	-17,679 Reduced 51.82%	16,434 $343,000
Q1 2020 May 14, 2020	SELL	$7.98 - $16.32 $39,652 - $81,094	-4,969 Reduced 12.71%	34,113 $333,000
Q4 2019 Feb 13, 2020	BUY	$5.12 - $12.22 $80,542 - $192,232	15,731 Added 67.37%	39,082 $450,000
Q3 2019 Nov 12, 2019	SELL	$5.24 - $15.89 $6,817 - $20,672	-1,301 Reduced 5.28%	23,351 $127,000
Q2 2019 Aug 13, 2019	BUY	$5.1 - $11.89 $125,725 - $293,112	24,652 New	24,652 $293,000
Q4 2018 Feb 05, 2019	SELL	$2.87 - $5.92 $238,204 - $491,348	-82,998 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $274,288 - $463,242	-60,953 Reduced 42.34%	82,998 $502,000
Q2 2018 Aug 10, 2018	BUY	$5.3 - $6.9 $762,940 - $993,261	143,951 New	143,951 $763,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $391M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.